As in Amgen taking say 50M shares at something like $4, but the deal is contingent on placing someone of their choosing at the helm?
Same here, 'firmly entrenched' as well - will be buying more if they drop us down significantly.
Wondering if it is mostly retail who finally gave up after that call and following dilution announcement. A real shame - these guys definitely play hardball. Hopefully the next 30 or 40 million to cover has much greater positive effect on the share price.
Obviously that would only happen with some type of partnership news or equity stake, or some regional approval news. May 9th isn't long away though.
One would have expected some type of updates on progress on multiple fronts. This is the same old Matt is seems.
Sadly, have to agree. Obviously Al recognized that Matt wasn't CEO material, but when the DeSisto recruitment collapsed I think Al and the BoD had little time.
Sentiment: Strong Buy